Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 88

1.

Influence of RGS2 on sertraline treatment for social anxiety disorder.

Stein MB, Keshaviah A, Haddad SA, Van Ameringen M, Simon NM, Pollack MH, Smoller JW.

Neuropsychopharmacology. 2014 May;39(6):1340-6. doi: 10.1038/npp.2013.301. Epub 2013 Oct 24.

PMID:
24154666
[PubMed - in process]
2.

Influence of RGS2 on anxiety-related temperament, personality, and brain function.

Smoller JW, Paulus MP, Fagerness JA, Purcell S, Yamaki LH, Hirshfeld-Becker D, Biederman J, Rosenbaum JF, Gelernter J, Stein MB.

Arch Gen Psychiatry. 2008 Mar;65(3):298-308. doi: 10.1001/archgenpsychiatry.2007.48.

PMID:
18316676
[PubMed - indexed for MEDLINE]
3.

Clinical evaluation of the efficacy and safety of tandospirone versus sertraline monotherapy for social anxiety disorder: a randomized open-label trial.

Huang X, Li C, Li WH, Luo YL, Wang B, Zhang W, Gan JJ, Ji JL.

Hum Psychopharmacol. 2013 Nov;28(6):594-9. doi: 10.1002/hup.2361.

PMID:
24519693
[PubMed - in process]
4.

Serotonin transporter gene promoter polymorphism predicts SSRI response in generalized social anxiety disorder.

Stein MB, Seedat S, Gelernter J.

Psychopharmacology (Berl). 2006 Jul;187(1):68-72. Epub 2006 Mar 9.

PMID:
16525856
[PubMed - indexed for MEDLINE]
5.

Internet-based cognitive behavior therapy vs. cognitive behavioral group therapy for social anxiety disorder: a randomized controlled non-inferiority trial.

Hedman E, Andersson G, Ljótsson B, Andersson E, Rück C, Mörtberg E, Lindefors N.

PLoS One. 2011 Mar 25;6(3):e18001. doi: 10.1371/journal.pone.0018001.

PMID:
21483704
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

A randomized controlled trial of venlafaxine extended release in generalized social anxiety disorder.

Liebowitz MR, Mangano RM, Bradwejn J, Asnis G; SAD Study Group.

J Clin Psychiatry. 2005 Feb;66(2):238-47.

PMID:
15705011
[PubMed - indexed for MEDLINE]
7.

A 5-Year follow-up of internet-based cognitive behavior therapy for social anxiety disorder.

Hedman E, Furmark T, Carlbring P, Ljótsson B, Rück C, Lindefors N, Andersson G.

J Med Internet Res. 2011 Jun 15;13(2):e39. doi: 10.2196/jmir.1776.

PMID:
21676694
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Paroxetine : a review of its pharmacology and therapeutic potential in the management of panic disorder.

Foster RH, Goa KL.

CNS Drugs. 1997 Aug;8(2):163-88. doi: 10.2165/00023210-199708020-00010.

PMID:
23338224
[PubMed]
9.

Further evidence for association of the RGS2 gene with antipsychotic-induced parkinsonism: protective role of a functional polymorphism in the 3'-untranslated region.

Greenbaum L, Smith RC, Rigbi A, Strous R, Teltsh O, Kanyas K, Korner M, Lancet D, Ben-Asher E, Lerer B.

Pharmacogenomics J. 2009 Apr;9(2):103-10. doi: 10.1038/tpj.2008.6. Epub 2008 Mar 18.

PMID:
18347610
[PubMed - indexed for MEDLINE]
10.

Social anxiety disorder: radio electric asymmetric conveyor brain stimulation versus sertraline.

Fontani V, Mannu P, Castagna A, Rinaldi S.

Patient Prefer Adherence. 2011;5:581-6. doi: 10.2147/PPA.S27409. Epub 2011 Nov 22.

PMID:
22163157
[PubMed]
Free PMC Article
11.

Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery.

Mead GE, Hsieh CF, Lee R, Kutlubaev MA, Claxton A, Hankey GJ, Hackett ML.

Cochrane Database Syst Rev. 2012 Nov 14;11:CD009286. doi: 10.1002/14651858.CD009286.pub2. Review.

PMID:
23152272
[PubMed - indexed for MEDLINE]
12.

Efficacy of sertraline in severe generalized social anxiety disorder: results of a double-blind, placebo-controlled study.

Liebowitz MR, DeMartinis NA, Weihs K, Londborg PD, Smith WT, Chung H, Fayyad R, Clary CM.

J Clin Psychiatry. 2003 Jul;64(7):785-92.

PMID:
12934979
[PubMed - indexed for MEDLINE]
13.

Internet treatment for social anxiety disorder in Romania: study protocol for a randomized controlled trial.

Tulbure BT, Månsson KN, Andersson G.

Trials. 2012 Oct 30;13:202. doi: 10.1186/1745-6215-13-202.

PMID:
23111108
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Association of RGS2 variants with panic disorder in a Japanese population.

Otowa T, Shimada T, Kawamura Y, Sugaya N, Yoshida E, Inoue K, Yasuda S, Liu X, Minato T, Tochigi M, Umekage T, Kasai K, Tanii H, Okazaki Y, Kaiya H, Sasaki T.

Am J Med Genet B Neuropsychiatr Genet. 2011 Jun;156B(4):430-4. doi: 10.1002/ajmg.b.31178. Epub 2011 Mar 22.

PMID:
21438143
[PubMed - indexed for MEDLINE]
15.

An open trial of paroxetine for the "offensive subtype" of taijin kyofusho and social anxiety disorder.

Nagata T, van Vliet I, Yamada H, Kataoka K, Iketani T, Kiriike N.

Depress Anxiety. 2006;23(3):168-74.

PMID:
16456863
[PubMed - indexed for MEDLINE]
16.

Screening for social anxiety disorder in the clinical setting: using the Liebowitz Social Anxiety Scale.

Mennin DS, Fresco DM, Heimberg RG, Schneier FR, Davies SO, Liebowitz MR.

J Anxiety Disord. 2002;16(6):661-73.

PMID:
12405524
[PubMed - indexed for MEDLINE]
17.

[Efficacy and tolerability of escitalopram in anxiety disorders: a review].

Pelissolo A.

Encephale. 2008 Sep;34(4):400-8. doi: 10.1016/j.encep.2008.04.004. Epub 2008 Aug 15. Review. French.

PMID:
18922243
[PubMed - indexed for MEDLINE]
18.

A 24-week randomized, double-blind, placebo-controlled study of escitalopram for the prevention of generalized social anxiety disorder.

Montgomery SA, Nil R, Dürr-Pal N, Loft H, Boulenger JP.

J Clin Psychiatry. 2005 Oct;66(10):1270-8.

PMID:
16259540
[PubMed - indexed for MEDLINE]
19.

Resistant social anxiety disorder response to Escitalopram.

Pallanti S, Quercioli L.

Clin Pract Epidemiol Ment Health. 2006 Dec 13;2:35.

PMID:
17166264
[PubMed]
Free PMC Article
20.

Open-label treatment with escitalopram in patients with social anxiety disorder and fear of blushing.

Pelissolo A, Moukheiber A.

J Clin Psychopharmacol. 2013 Oct;33(5):695-8. doi: 10.1097/JCP.0b013e31829a878b.

PMID:
23948787
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk